Skip to content

Clinical trials

Phase 3 Genetic Diseases, Inborn trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 3 Country / region: India Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20172
20183
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company2
Quince Therapeutics S.p.A.2
Regeneron Pharmaceuticals2
Forma Therapeutics, Inc.1
PTC Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn8
Genetic Diseases, X-Linked3
Hematologic Diseases3
Musculoskeletal Diseases3
Arthritis2
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders2
Gout2
Hemophilia A2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.